Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium Global Research on the tissue ablation market provides an in-depth analysis of segments and sub-segments in the global as well as regional tissue ablation market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional tissue ablation market over the short term as well as the long term. The report is a comprehensive presentation of trends, forecasts, and dollar values of the global tissue ablation market. According to the report, the global tissue ablation market is projected to grow at a CAGR of nearly 8% over the forecast period of 2022-2028.
The global tissue ablation market was valued at over USD 1200 Million in 2022 and is expected to reach about USD 2000 Million in 2028, with a CAGR of nearly 8% during the forecast period. Tissue ablation is the process of eradication of unhealthy tissues to stop disease proliferation. Tissue ablation is minimally invasive in nature and thus it's the foremost preferred choice of treatment. It uses Ultrasound, Radiofrequency, Microwave, and lots of other methods for the eradication of diseased tissues. The key factors contributing to the expansion of tissue ablation methods include a rapid increase in the occurrence of chronic diseases, increase awareness, and increased training programs conducted by manufacturers for professionals on the utilization of tissue ablation equipment. Tissue ablation procedures are the foremost advanced methods used for treating various medical conditions from cancer to aesthetic procedures which have enhanced the expansion of the market.
The increasing prevalence of chronic diseases; rising adoption of minimally invasive surgeries; ongoing technological advancements within the field of ablation devices, growing awareness about the advantages of ablation procedures over conventional therapeutic and surgical procedures, and therefore the rising number of hospitals and surgical centers are a number of the most important factors driving the expansion of the worldwide tissue ablation market. These driving factors consequence in the rapid adoption of those new devices, thus propelling the market growth. The increasing inclination of surgeons and patients toward minimally invasive procedures attributable to the advantages like speedy recovery, patient comfort, and reduced work time are the factors expected to drive the demand for tumor ablation technology during the forecast period. Additionally, a rise within the demand for minimally invasive treatment options and increased government initiatives to develop healthcare infrastructure in developing countries will create lucrative growth opportunities. However high treatment costs, complications related to ablation technologies, and stringent regulatory policies may act as a restraint on the expansion of the tissue ablation market during the forecast period.
The COVID-19 epidemic had an inconsequential effect on the tissue ablation market during the forecast period. The outbreak of COVID-19 has made a significant impact on the tissue ablation system market outlook because the surgical practices were affected because of the lockdown restrictions and growing concerns among patients about the danger of coronavirus infection. Various surgical procedures were temporarily halted so as to satisfy the increasing healthcare demand during the pandemic. However, because the healthcare sector is releasing the security norms regarding coronavirus and going back to concluding surgical procedures, the market is estimated to grow significantly during the forecast period.
The global tissue ablation market is segmented into the Asia Pacific, North America, Europe, the Middle East & Africa, and South America. Among the regions, North America is anticipated to dominate the tissue ablation market during the forecast period. There’s considerable growth in this region, because of the increasing aged population, rising number of chronic diseases, and therefore the existence of the many local and international manufacturers of tissue ablation devices in this region. The Asia Pacific region is expected to be the fastest-growing region during the forecast period. The rapid increase in the geriatric population is anticipated to fuel the expansion of the tissue ablation market within the Asia Pacific region during the forecast period.
The report on the global tissue ablation market covers segments such as device technology, and application. On the basis of device technology, the sub-markets include radiofrequency devices, laser/light ablation, ultrasound devices, cryoablation devices, and others. On the basis of application, the sub-markets include cardiovascular disease treatment, cancer treatment, ophthalmologic treatment, gynecological treatment, cosmetic surgery, urological treatment, and others.
The report provides profiles of the companies in the market such as Integra LifeSciences Corporation, Ethicon, Inc., Misonix Inc., Boston Scientific Corporation, Johnson & Johnson, Medtronic, Abbott Laboratories, Smith & Nephew Plc, Stryker Corporation, and Theraclion.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of the tissue ablation market. Moreover, the study highlights current
market trends and provides forecasts from 2022-2028. We also have highlighted
future trends in the market that will affect the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
an insight into the market share of the leading players.
Please Choose One of them.